TIS 0.00% 0.0¢ tissue therapies limited

Well done Steve and team !, page-28

  1. 66 Posts.
    ajbhu - perhaps I miss but I do not see an economic study on VITROGRO. appended hyperlink points to 3 papers around chronic wounds but not specific to VITROGRO. One review summarises cost of chronic wounds in Germany but not to VITROGRO. I would be most interested in the paper you write of. Is it possible you could send new link? thank you
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.